SBC Medical Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $4.11 High: $4.35
on October 7, 2025

52 Week Range

Low: $2.62 High: $8.83
on March 6, 2025
on October 9, 2024

All-Time High: $49,900.00 on June 21, 2010

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $456.6M
EPS i 0.32
P/E Ratio (TTM) i 13.22
Forward P/E i 0.40
P/B Ratio i 1.78
PEG Ratio i -0.15
Div. Yield i N/A
ROE i 16.44%
Beta i 1.289
Debt to Equity i 6.35

Financial Highlights

Profitability

Gross Margin i 69.21%
Operating Margin i 33.57%
Profit Margin i 17.71%

Returns and Earnings

Return on Assets (TTM) i 15.86%
Return on Equity (TTM) i 16.44%
EBITDA i $73.6M
Net Income (TTM) i $33.3M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i $1.83
Quarterly Revenue Growth (YoY) i -18.30%
Quarterly Earnings Growth (YoY) i -86.70%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
SBC Medical SBC 456.58M Small-cap-5.07%-17.43%-15.23%21.18%-25.77%-45.43%-62.68%-62.68%
Verisk Analytics VRSK 34.79B Large-cap-2.15%-9.87%-20.14%-11.51%-9.99%-8.25%47.50%27.86%
Equifax EFX 29.36B Large-cap-7.23%-5.92%-9.88%14.04%-5.23%-16.55%49.59%45.70%
Icf International ICFI 1.74B Small-cap-0.38%-3.19%4.59%13.03%-21.60%-45.09%-17.86%35.86%
CRA International CRAI 1.30B Small-cap-8.12%-0.68%-2.11%18.46%4.60%1.15%107.12%378.38%
Booz Allen Hamilton BAH 12.84B Large-cap4.09%2.31%-5.79%-3.10%-18.79%-35.34%10.22%26.43%

Ownership & Short Interest

Insider Ownership i 89.24%
Institutional Ownership i 0.63%
Shares Short i 133K
Short Ratio i 2.74
Short % of Shares Outstanding i 1.35%
Average 10-Day Volume i 38K
Average 90-Day Volume i 60K

Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, SBC Medical reached a high of $8.83 (on October 9, 2024) and a low of $2.62 (on March 6, 2025).
Curious about SBC Medical's size and valuation? Its market capitalization stands at 456.58M. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.22, and the forward P/E (looking ahead) is 0.40.
As for dividends, SBC Medical isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at SBC Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Verisk Analytics
VRSK
34.79BIndustrialsConsulting Services-8.25%47.50%
Equifax
EFX
29.36BIndustrialsConsulting Services-16.55%49.59%
Icf International
ICFI
1.74BIndustrialsConsulting Services-45.09%-17.86%
CRA International
CRAI
1.30BIndustrialsConsulting Services1.15%107.12%
Booz Allen Hamilton
BAH
12.84BIndustrialsConsulting Services-35.34%10.22%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of SBC Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.44%, the Debt to Equity ratio from the most recent quarter is 6.35, and its Gross Profit Margin stands at 69.21%.
Looking at SBC Medical's growth, its revenue over the trailing twelve months (TTM) was $188M. Compared to the same quarter last year (YoY), quarterly revenue grew by -18.30%, and quarterly earnings saw a YoY growth of -86.70%.
Wondering who owns SBC Medical stock? Company insiders (like executives and directors) hold about 89.24% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.63%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.